The risk factors of future exacerbations and treatment responses among different inhalation therapies of patients with preserved ratio impaired spirometry. [PDF]
Cao J +12 more
europepmc +1 more source
Budesonide/formoterol fumarate dihydrate <i>versus</i> budesonide with a novel suspension technology for uncontrolled asthma: phase 3 VATHOS study. [PDF]
Jackson DJ +12 more
europepmc +1 more source
Signaling Bias as a Framework for Therapeutically Relevant Orthosteric Agonists: The β<sub>2</sub> Adrenergic Receptor Paradigm. [PDF]
Georgiou K, Kolocouris A.
europepmc +1 more source
Reported use of anti-asthmatic medication in doping control forms from 2015 to 2019 - mapping retrospective data. [PDF]
Kojen AJ +5 more
europepmc +1 more source
Pediatric Mild Asthma: Bridging Current Gaps to Improve Future Care. [PDF]
Santamaria F, Fontanella C, Borrelli M.
europepmc +1 more source
Recurrent Spasmodic Croup-Like Episodes With Cough-Predominant Symptoms in an Atopic School-Aged Child: The Importance of Integrated Upper- and Lower-Airway Management. [PDF]
Sakaguchi R +4 more
europepmc +1 more source
Abediterol (LAS100977), a novel long-acting β2-agonist: Efficacy, safety and tolerability in persistent asthma [PDF]
SummaryBackgroundAbediterol (LAS100977) is a novel, long-acting β2-agonist, in development for the once-daily treatment of asthma in combination with mometasone.
J Beier, R Fuhr
exaly +2 more sources
Related searches:

